Molecular Biometrics developed a proprietary near infrared (NIR) biospectroscopy
platform for its metabolomic applications.
He was also the founding Editor of the journal Biospectroscopy
that subsequently merged with Biopolymers, and he is currently Editor-in-Chief of the Journal of Raman Spectroscopy.
New research demonstrates proof-of-concept for diagnosing Parkinson's disease using non-invasive, biospectroscopy technology
Davis - Jewish General Hospital and McGill University have shown that, using biospectroscopy methods to create a specific biomarker profile, they can distinguish idiopathic Parkinson's disease from normal aging and other neurodegenerative conditions.
We created a biomarker profile, using biospectroscopy techniques, to delineate a chemical signature in blood that identifies patients with Parkinson's disease," said Hyman M.
The data from this study showed that the two independent biospectroscopy measurement techniques yielded similar and consistent results.
In related news, John Wiley (New York) has merged Biospectroscopy
and Biopolymers to form Bioploymers: Biospectroscopy
Molecular Biometrics' advancement of biospectroscopy
and metabolomic technologies may hold significant potential to more accurately assess the reproductive potential of individual embryos.
The company is applying its patented application of biospectroscopy -- light analysis technology -- and bioinformatics to develop diagnostic tools in five areas of medicine.
Near infrared (NIR) biospectroscopy, when applied with metabolomic analysis, evaluates the absorption of light specific to small molecule functional groups, to create a biomarker profile of molecules that are descriptive of cellular function and viability.